Page last updated: 2024-10-22

pimagedine and Inflammatory Response Syndrome, Systemic

pimagedine has been researched along with Inflammatory Response Syndrome, Systemic in 2 studies

pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takano, H1
Yoshikawa, T1
Yamaguchi, T1
Hongo, H1
Fujii, T1
Boku, Y1
Yoshida, N1
Yamamoto, H1
Nakahashi, Y1
Yanagisawa, R1
Kondo, M1
Hayashi, Y1
Sawa, Y1
Fukuyama, N1
Nakazawa, H1
Matsuda, H1

Other Studies

2 other studies available for pimagedine and Inflammatory Response Syndrome, Systemic

ArticleYear
Effects of aminoguanidine on systemic inflammatory response syndrome induced by platelet activating factor and by lipopolysaccharide in rats.
    European journal of pharmacology, 1997, Mar-26, Volume: 323, Issue:1

    Topics: Animals; Disease Models, Animal; Enzyme Induction; Enzyme Inhibitors; Guanidines; Injections, Intrav

1997
Inducible nitric oxide production is an adaptation to cardiopulmonary bypass-induced inflammatory response.
    The Annals of thoracic surgery, 2001, Volume: 72, Issue:1

    Topics: Animals; Cardiopulmonary Bypass; Endothelium, Vascular; Enzyme Induction; Guanidines; Interleukin-6;

2001